Company news

Rhythm Biosciences Limited news in 2020

Rhythm Biosciences Limited's news releases, calls and decks from 2020, newest first.

View company

Investor Presentation - December 2020

December 20, 2020

Rhythm Secures US Patent - Strengthens Global Footprint

December 16, 2020

Rhythm Appoints Global Manufacturer for ColoSTAT

December 1, 2020

AGM Presentation - November 2020

November 17, 2020

ColoSTAT Prototype Complete, Outperforms FIT

November 11, 2020

Ethics Approval Received, New Clinical Trial Site Added

October 26, 2020

Rhythm Receives $1.1m R&D Tax Incentive

October 15, 2020

Final Two Adjunct Biomarkers Technically Validated

September 28, 2020

New Clinical Trial Site Contracted and Recruiting

September 22, 2020

Rhythm Successfully Validates Two Adjunct Biomarkers

September 15, 2020

Revised CEO Contract and LTIP for all employees - amended

September 14, 2020

Revised CEO Contract and LTIP initiated for all employees

September 13, 2020

Addtl Clinical Trial Site Signed - First Patient Recruited

September 9, 2020

Non-renounceable rights issue Offer

July 31, 2020

Placement & Rights Offer to raise approximately $6 million

July 22, 2020

COVID-19 Update

April 8, 2020

Successful ISO13485 Surveillance Audit

April 5, 2020

Rhythm Successfully Validates Key Biomarker

April 1, 2020

Decks in 2020